Your browser doesn't support javascript.
loading
Pomalidomide-bortezomib-dexamethasone in relapsed or refractory multiple myeloma: Japanese subset analysis of OPTIMISMM.
Sunami, Kazutaka; Matsue, Kosei; Suzuki, Kenshi; Takezako, Naoki; Shinagawa, Atsushi; Sakurai, Sanae; Tamakoshi, Hiromi; Biyukov, Tsvetan; Peluso, Teresa; Richardson, Paul.
Afiliación
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Matsue K; Department of Hematology, Kameda Medical Center, Chiba, Japan.
  • Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Takezako N; Department of Hematology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Shinagawa A; Department of Hemato-Oncology, Hitachi General Hospital, Ibaraki, Japan.
  • Sakurai S; Department of Clinical Research & Development Study, Celgene KK, a Bristol-Myers Squibb Company, Tokyo, Japan.
  • Tamakoshi H; Department of Clinical Research & Development Study, Celgene KK, a Bristol-Myers Squibb Company, Tokyo, Japan.
  • Biyukov T; Department of Clinical R&D Management, Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland.
  • Peluso T; Department of Clinical R&D Management, Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland.
  • Richardson P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Cancer Sci ; 111(6): 2116-2122, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32297407

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Sci Año: 2020 Tipo del documento: Article País de afiliación: Japón
...